Vascular endothelial growth factor expression in invasive ductal carcinoma of breast

Chinese Journal of Cancer Research

Volumn 19, Issue 1, 2007, Pages 56-59

  Xu, Wei Guo ^a   Wang, Gang ^a   Zou, Yu Huan ^a   Song, Ji Ning ^a   Yang, Xiao Qing ^a   Wang, Wen Ya ^a  

^a NORTH CHINA COAL MEDICAL COLLEGE   (China)

Author keywords

Invasive ductal carcinoma of breast; MVD; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CARCINOGENESIS; CANCER STAGING; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 34147116196     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-007-0056-y     Document Type: Article

References (17)

1. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [J]. J Natl Cancer Inst 1992; 84:1875-87.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent [J]? J Natl Cancer Inst 1990; 82:4-6.
3. Tsutsui S, Kume M, Era S, et al. Prognostic value of microvessel density in invasive ductal carcinoma of the breast [J]. Breast Cancer 2003; 10:312-9.
4. Chen YB, Wan DS, Zhan YQ, et al. Correlation of tumor microvessel density to metastasis and recurrence of rectal cancer [J]. Ai Zheng (Chin) 2004; 23:1203-6.
5. Zhu ZH, Rong TH, Zeng CG, et al. Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances [J]. Ai Zheng (Chin) 2005; 24:865-9
6. Chhieng DC, Tabbara SO, Marley EF, et al. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma [J]. Breast J 2003; 9:200-7.
7. Martin L, Green B, Renshaw C, et al. Examining the technique of angiogenesis assessment in invasive breast cancer [J]. Br J Cancer 1997; 76:1046-54.
8. Elagoz S, Egilmez R, Koyuncu A, et al. The intratumoral micro -vessel density and expression of bFGF and nm23-H1 in colorectal cancer [J]. Pathol Oncol Res 2006; 12:21-7.
9. Ahmed SI, Thomas AL, Steward WP, et al. Vascular endothelial growth factor (VEGF) inhibition by small molecules [J]. J Chemother 2004; 16(Suppl):59-63.
10. Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factors [J]. Cardiovasc Res 2005; 65:550-63.
11. Witmer AN, Dai J, Weich HA, et al. Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J Histochem Cytochem 2002; 50:767-77.
12. Takashima S, Kitakaze M, Asakura M, et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis [J]. Proc Natl Acad Sci USA 2002; 99:3657-62.
13. Gunningham SP, Currie MJ, Han C, et al. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis [J]. J Pathol 2001; 193:325-32.
14. Zhang LJ, Yang GL, Xu WQ et al. Expression of VEGF in primary non-small cell lung carcinoma [J]. Chin J Cancer Res 1999; 11:288-91.
15. Xu WQ Yang GL, Zhou LX, et al. Prognostic value of Vascular Endothelial Growth Factor expression in primary esophageal squamous cell carcinoma [J]. Chin J Cancer Res 2004; 16:85-9.
16. Li BJ, Zhu ZH, Wang JY, et al. Expression correlation of Ki67 to p53, VEGF, and C-erbB-2 genes in breast cancer and their clinical significances [J]. Ai Zheng (Chin) 2004; 23:1176-9.
17. Konecny GE, Meng YG, Untch M, et al. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients [J]. Clin Cancer Res 2004; 10:1706-16.